Patents by Inventor Christopher Lademacher

Christopher Lademacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING HYPERTENSION
    Publication number: 20140329868
    Abstract: The present invention relates to methods of treating subjects suffering from pre-hypertension or hypertension by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: April 7, 2014
    Publication date: November 6, 2014
    Inventors: Christopher Lademacher, Lin Zhao, Nancy Joseph-Ridge, Richard Johnson
  • METHODS FOR PRESERVING AND/OR INCREASING RENAL FUNCTION USING XANTHINE OXIDOREDUCTASE INHIBITORS
    Publication number: 20090124623
    Abstract: The present invention relates to methods of preserving or increasing renal function in a subject in need thereof by administering a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof. The present invention also relates to methods of increasing renal function in a subject in need thereof by administering a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: September 14, 2008
    Publication date: May 14, 2009
    Inventors: Christopher Lademacher, Patricia MacDonald, Andrew Whelton
  • Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents
    Publication number: 20090042887
    Abstract: The present invention relates to methods of preventing gout flares in a subject in need thereof by administering to the subject a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof and at least one non-steroidal anti-inflammatory drug for a period of six months on a regular basis.
    Type: Application
    Filed: January 17, 2008
    Publication date: February 12, 2009
    Applicant: TAP Pharmaceutical Products, Inc.
    Inventors: Christopher Lademacher, Patricia McDonald, Nancy Joseph Ridge, Rajneesh Taneja
  • Methods for Preserving Renal Function Using Xanthine Oxidoreductase Inhibitors
    Publication number: 20080269226
    Abstract: The present invention relates to methods of preserving renal function in a subject in need thereof by administering a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: November 13, 2007
    Publication date: October 30, 2008
    Inventors: Christopher Lademacher, Patricia MacDonald
  • Methods for treating hypertension
    Publication number: 20070167454
    Abstract: The present invention relates to methods of treating subjects suffering from pre-hypertension or hypertension by administering to a subject in need of treatment thereof a therapeutically effective amount of at least one xanthine oxidoreductase inhibiting compound or salt thereof.
    Type: Application
    Filed: August 2, 2006
    Publication date: July 19, 2007
    Inventors: Christopher Lademacher, Lin Zhao, Nancy Joseph-Ridge, Richard Johnson